Pilot Studies for the Spectrum of Alzheimer’s Disease/Alzheimer’s Disease-Related Dementias and Age-Related Cognitive Decline (R61)

The purpose of this grant is to invite research grant applications that enable the collection of pilot data to support early stage testing of promising pharmacological and non-pharmacological interventions for cognitive and neuropsychiatric changes associated with age-related cognitive decline and Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD) across the spectrum from pre-symptomatic to more severe stages of disease, and to stimulate studies to enhance trial design and methods.

Funding: $325,000 per year 

Duration: 2 years

Research Authority due date: 10 days prior to submission

LOI (encouraged) due dates: 17.1.23, 19.5.23, 18.9.23, 20.1.24, 18.5.24, 18.9.24

Full proposal due dates: 17.2.23, 19.6.23, 18.10.23, 20.2.24, 18.6.4, 18.10.24